Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes
about
Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.RNA dimerization defect in a Rous sarcoma virus matrix mutant.HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchStructural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoproteinBiophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix proteinInteraction of the human immunodeficiency virus type 1 nucleocapsid with actin.Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmissionThe putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cellsA bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent mannerEnhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyproteinEvaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitorsRedundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.Deletions in the fifth alpha helix of HIV-1 matrix block virus release.Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.Second-site compensatory mutations of HIV-1 capsid mutations.A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particlesThe Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionThe frantic play of the concealed HIV envelope cytoplasmic tail.The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.
P2860
Q24523051-063904AD-2B92-4860-AE79-0C17E814CF49Q24524289-EEAB2084-680D-428A-8C51-A50E7C8A4FEFQ26746070-4A4AD174-F836-40AE-A461-50DDC35E5C05Q27485636-DBDA4D28-7A5D-4BA1-B0FA-9F644642E280Q27678797-5984AECE-E1C3-499F-8186-E407655B6DD8Q33643700-BDE7AB6A-4080-46E1-988F-F6313A307804Q33652796-83F08EC6-3381-427A-8970-4FFEA73736EEQ33782776-AE16629C-06EE-4D5C-AACE-799EF0E95382Q33785367-3F34984E-BB06-4CE2-8A2D-53EA8476C0DAQ33806715-EDA95B35-8399-4E00-8F96-DEE3DDBE6038Q33814996-91804DB7-98E4-4486-90E0-C818994CEEA5Q33822789-4FC84760-B7C2-4266-8BFD-6489332CF377Q33979580-0BDBDE03-8E6D-44CE-8DD6-EAD061D91FEDQ34123957-DB3997F9-FBDD-4467-95D4-58F9523921F2Q34179686-C00DF722-9698-462B-BE49-E5C5337372FFQ34620716-6A128C7E-B12F-4F42-88CA-82B9973F1988Q34828531-551B7DC5-9BA3-4E65-9FEC-B62371C03A4AQ35076692-C1BABE39-CF7F-4FF9-984B-64539CE074B1Q35826475-D49965D4-8EAB-488A-9D20-0AA6AD004978Q36123960-A2EDC8FF-D6E6-4095-A9B4-A1F85A0A9F0EQ36940646-67CD5200-E59D-4D49-B88D-041395AB10AFQ37152680-E511B056-2C47-4ABB-BCE3-C9B4F74969A8Q39244695-884B4E37-465A-4792-AA8D-70A1C2B2DE59Q39551677-ED73C1BE-F443-4709-AA3F-4CC25D11119FQ49900491-EDBA6A6B-80A8-4FB3-A0EF-11417C87A91F
P2860
Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@ast
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@en
type
label
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@ast
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@en
prefLabel
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@ast
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@en
P2093
P2860
P1433
P1476
Mutations in the matrix protei ...... proteins in CD4+ T lymphocytes
@en
P2093
P2860
P304
P407
P577
1997-02-01T00:00:00Z